LEADER 02219nam  2200541 a 450 
001 9910460194703321
005 20200520144314.0
010   $a1-282-66043-8
010   $a9786612660436
010   $a0-309-15322-0
035   $a(CKB)2670000000040032
035   $a(EBL)3378635
035   $a(SSID)ssj0000414722
035   $a(PQKBManifestationID)11294360
035   $a(PQKBTitleCode)TC0000414722
035   $a(PQKBWorkID)10394927
035   $a(PQKB)11483878
035   $a(MiAaPQ)EBC3378635
035   $a(Au-PeEL)EBL3378635
035   $a(CaPaEBR)ebr10399497
035   $a(CaONFJC)MIL266043
035   $a(OCoLC)659579790
035   $a(EXLCZ)992670000000040032
100   $a20100805d2010      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aConsiderations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches$b[electronic resource] $esummary of a workshop /$fJeffrey Fox, Marilee Shelton-Davenport, and India Hook-Barnard ; Board on Life Sciences, Division on Earth and Life Studies
210   $aWashington, D.C. $cNational Academies Press$d2010
215   $a1 online resource (39 p.)
300   $aDescription based upon print version of record.
311   $a0-309-15321-2 
327   $a""Front Matter""; ""PREFACE""; ""ACKNOWLEDGMENTS""; ""CONTENTS""; ""INTRODUCTION/PLATFORMS FOR LARGE-SCALE MONOCLONAL ANTIBODY PRODUCTION/PLATFORMS FOR VACCINE PRODUCTION/SUMMARY OF KEY POINTS ""; ""Appendix A   Statement of Task""; ""Appendix B   AGENDA""; ""Appendix C   Biographies""
606   $aVaccination$vCongresses
608   $aElectronic books.
615  0$aVaccination
676   $a358.38
712 02$aNational Research Council (U.S.).$bBoard on Life Sciences.
712 02$aNational Research Council (U.S.).$bDivision on Earth and Life Studies.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910460194703321
996   $aConsiderations for ensuring safety and efficacy of vaccines and therapeutic proteins manufactured by using platform approaches$92289789
997   $aUNINA